NV
Nikhitha Veerla
About Nikhitha Veerla
Data last updated:
Nikhitha Veerla is a Director at Elinova Pharma Private Limited (since 2024) and Director at Sgn Pharma Private Limited (since 2023). The companies operate in Food And Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹1.25 Cr; the largest is Elinova Pharma Private Limited at ₹1.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Elinova Pharma Private Limited U24304TG2017PTC118555 | Director | 08 Aug 2024 | 2017 | ₹1.25 Cr (FY 2024) | Active |
| Sgn Pharma Private Limited U46497TS2023PTC175895 | Director | 09 Aug 2023 | 2023 | ₹68,409 (FY 2024) | Active |
Board colleagues of Nikhitha Veerla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jayalaxmi Jangiti | 07874374 | Elinova Pharma Private Limited , Sgn Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhitha Veerla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhitha Veerla
Nikhitha Veerla currently holds 2 directorships: Elinova Pharma Private Limited (Director, since 08 Aug 2024, revenue ₹1.25 Cr (FY 2024)); Sgn Pharma Private Limited (Director, since 09 Aug 2023, revenue ₹68,409 (FY 2024)).
Nikhitha Veerla was first appointed on 09 Aug 2023 as Director at Sgn Pharma Private Limited. The most recent appointment on record is 08 Aug 2024 at Elinova Pharma Private Limited.
The 2 current companies of Nikhitha Veerla that report revenue have a combined latest revenue of ₹1.25 Cr: Elinova Pharma Private Limited ₹1.25 Cr (FY 2024); Sgn Pharma Private Limited ₹68,409 (FY 2024).
The current boards of Nikhitha Veerla's companies include Jayalaxmi Jangiti (Elinova Pharma Private Limited).